OR05-04 Steroid Receptor Co-Activators Complexes Cooperate with Progesterone Receptors (PR) to Reprogram Metabolic Pathways that Drive Therapy Resistant Populations in ER+ Breast Cancer

Late recurrence of metastatic disease stemming from acquired therapy resistance remains a significant health burden for women with ER+ breast cancer. Disseminated ER+ tumor cell populations can remain quiescent for years to decades, and contributing factors include breast cancer stem cells (CSCs), w...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Thu H, Benner, Elizabeth, Ostrander, Julie Hanson, Lange, Carol A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208123/
http://dx.doi.org/10.1210/jendso/bvaa046.1307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208123/
http://dx.doi.org/10.1210/jendso/bvaa046.1307

Ejemplares similares